Research
Profile (Community of Science)
Research Program:
Dr. Schellenberg's research program focuses on neurodegenerative diseases
and behavioral disorders. The neurodegenerative diseases he is studying
include Alzheimer's disease, frontotemporal dementia, progressive supranuclear
palsy and related tauopathies, and amyotrophic lateral sclerosis/parkinsonism
dementia complex (ALS/PDC)of Guam. He is using linkage and disequilibrium
analysis to identify genetic loci for late-onset Alzheimer's disease
and ALS/PDC. Recently his laboratory identified tau as the gene responsible
inherited forms of frontotemporal dementia. Dr. Schellenberg's laboratory
is now determining how these mutations affect tau gene regulation and
the biochemical function of the tau protein, and how different mutations
lead to different disease phenotypes. Work is now in progress to identify
the cis and trans-acting factors that regulate the
tau gene.
Dr. Schellenberg's group is also using linkage analysis to identify
the genes responsible for two behavioral disorders, autism and schizophrenia.
The autism project is identifying families with two or more affected
subjects with autism. For each family, in addition to the affected siblings,
the parents and unaffected siblings are being evaluated by an extensive
battery of neuropsychological tests. The results will be used for quantitative
trait analysis to identify autism genes. Linkage analysis is also being
used to identify schizophrenia genes.
Investigator: Dr. Schellenberg is a Research Professor in the Division
of Gerontology and Geriatric Medicine, Department of Medicine and is
an adjunct Professor in the Departments of Pharmacology and Neurology.